IL17A and inflammatory bowel disease: Our finding is consistent with the observation that IBD patients with an AG or AA genotype of IL17A rs2275913 SNP are associated with nonresponse [26], and is contrary to the finding that female RA patients carrying the GG genotype are characterized by a poor response to anti-TNF treatment [25].